CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
Tadakazu Hisamatsu, Reiko Kunisaki, Shiro Nakamura, Tomoyuki Tsujikawa, Fumihito Hirai, Hiroshi Nakase, Kenji Watanabe, Kaoru Yokoyama, Masakazu Nagahori, Takanori Kanai, Makoto Naganuma, Hirofumi Michimae, Akira Andoh, Akihiro Yamada, Tadashi Yokoyama, Noriko Kamata, Shinji Tanaka, Yasuo Suzuki, Toshifumi Hibi, Mamoru Watanabe,
Intest Res. 2018;16(3):494-498.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.494

Excel Download

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
Intestinal Research. 2018;16(3):494   Crossref logo
Link1 Link2 Link3

Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis
Alimentary Pharmacology & Therapeutics. 2007;26(11-12):1509-1520   Crossref logo
Link1 Link2

W1335 Previous Non-Response to Infliximab Predicts Early Dose-Escalation in Adalimumab Treated Crohn's Disease Patients
Gastroenterology. 2010;138(5):S-701-S-702   Crossref logo
Link1 Link2

Sa1974 Rational Infliximab De-Escalation in Crohn's Patients in Remission Using Infliximab Levels
Gastroenterology. 2016;150(4):S421   Crossref logo
Link1 Link2

Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
The American Journal of Gastroenterology. 2009;104(3):760-767   Crossref logo
Link1 Link2 Link3

W1270 Discriminating Between Response Types in Infliximab-Treated Patients With Crohn's Disease: Sensitivity and Specificity of Combined Assessment of Infliximab Trough Levels and Anti-Drug Antibodies
Gastroenterology. 2010;138(5):S-687-S-688   Crossref logo
Link1 Link2

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing Crohn's disease receiving maintenance treatment with infliximab
Gastroenterology. 2003;124(4):A380   Crossref logo
Link1 Link2

Su1225 Concomitant Elemental Diet Therapy Is Effective in Sustaining Infliximab Scheduled Maintenance Therapy in Patients With Crohn's Disease to Prevent Loss of Response
Gastroenterology. 2013;144(5):S-433   Crossref logo
Link1 Link2

Outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients
Journal of Crohn's and Colitis. 2021;   Crossref logo
Link1 Link2

Infliximab dose intensification in patients with Crohn's disease
Nature Clinical Practice Gastroenterology & Hepatology. 2007;4(11):588-589   Crossref logo
Link1 Link2 Link3